Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-021521

CHIEF EXECUTIVE OFFICER sold 40,000 shares at $62.00 ($2,480,000)

  • CHIEF EXECUTIVE OFFICER acquired 40,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Peetz Christopher · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-11 Exercise or conversion : show line 1 in the form 10b5-1 +40,000 $2.94 $117,440 178,641 D
2025-08-11 Sale : show line 2 in the form 10b5-1 −40,000 $62.00 $2,480,000 138,641 D
Open-market sales · 40,000 sh · avg $62.00 · $2,480,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-11 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) −40,000 158,487 D
Loading xslF345X05/form4-08122025_110854.xml…